Automated CPR Devices Market is growing rapidly as Royal Philips receives the U.S. FDA premarket approval for its HeartStart FR3 and HeartStart FRx automated external defibrillators (AEDs)

 

Many new developments in the field of cardiopulmonary resuscitation (CPR) have led to the development of many advanced medical resuscitation technologies. Cardiopulmonary resuscitation (CPR) is a lifesaving technique used in numerous emergencies including heart attack, coronary artery disease (CAD), and heart valve disease. According to the Centers for Disease Control and Prevention (CDC), in 2017, around 365,914 people die due to CAD with around 18.2 million adults in the U.S. of age 20 years and above have CAD. Such massive incidence of heart diseases has increased the demand for appropriate medical devices. Thus, these factors can stimulate growth of the automated CPR devices market.

Automated CPR devices assist to deliver high frequency and consistent compressions during the cardiopulmonary resuscitation phase. This is critical to achieving maximum outcomes and reducing the chances of the victim losing consciousness as a result of ventricular tachycardia, ventricular fibrillation, or flutter heart rhythm. As far as geographical influence is considered, North America seems to be accumulating significant traction in the automated CPR devices market. This growth can be attributed to high geriatric population and technological advancements in medical devices. On the contrary, Europe is a key region registering promising signs due to a favorable regulatory framework and high disposable income. Recently, in June 2020, Royal Philips received the U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its HeartStart FR3 and HeartStart FRx automated external defibrillators (AEDs).

New and improved automated CPR devices are now being introduced into the marketplace to address new needs and to provide relief to individuals who experience sudden cardiac arrest. Most importantly, such devices are able to deliver consistent chest compressions with minimal effort on the behalf of the rescuer. However, there are several other factors that can pose major challenges in the development of the market. For instance, high costs associated with advanced equipment can limit the potential development of the market. Besides, lack of skilled personnel can inhibit growth of the automated CPR devices market.

Elderly people are most likely to require CPR devices due to high prevalence of heart diseases and weakened heart function. With rapidly growth geriatric population, the demand for CPR devices has surged significantly in the recent past. As per the World Health Organization (WHO), by 2050, the global population aged 65 years and above is expected to reach around 2 billion increasing from 900 million in 2015. Thus, such factors can bolster growth of the automated CPR devices market.